Ocuphire Pharma, Inc. ( OCUP) - Key Metrics
Stock symbol OCUP is outdated, potentially delisted? Maybe it is available on other exchange?
OCUP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.04 | -$0.30 | -$0.28 | -$0.28 |
| 2024Q1 | $0.07 | -$0.29 | -$0.23 | -$0.23 |
| 2023Q4 | $0.07 | -$0.21 | $0.20 | $0.20 |
| 2023Q3 | $0.56 | $0.26 | -$0.14 | -$0.14 |
| 2023Q2 | $0.18 | -$0.24 | $0.05 | $0.05 |
OCUP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -1.32 |
| 2024Q1 | ? | -1.92 |
| 2023Q4 | ? | -3.61 |
| 2023Q3 | ? | 3.23 |
| 2023Q2 | ? | -4.58 |
OCUP
Price: $1.17
52 week price:
Earnings Per Share: -0.54 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 340500
Market Capitalization: 31.7 million